NCT04654559

Brief Summary

Fever of infants up to 18 months of age will be monitored in the hospital using the standard clinical methods and wearable research prototypes. These research prototypes will be measuring continuously and non-invasively skin based parameters, with which the feasibility of developing a fever detection algorithm will be investigated.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 7, 2020

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 26, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 4, 2020

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
Last Updated

March 15, 2024

Status Verified

March 1, 2024

Enrollment Period

5 years

First QC Date

November 26, 2020

Last Update Submit

March 13, 2024

Conditions

Keywords

core body temperaturefeverwearable

Outcome Measures

Primary Outcomes (6)

  • Continuous and non-invasive skin temperature at the lateral rib cage position

    Skin temperature data collected continuously and non-invasively using a research prototype at the lateral ribcage. The skin temperature is measured directly underneath the research prototype on the surface of the skin in degree Celsius.

    Participants will be monitored continuously and unobtrusively with the research prototypes over a 1-3 day time period, depending on the stationary stay in the hospital

  • Continuous and non-invasive heat flux at the lateral rib cage position

    Heat flux data collected continuously and non-invasively using a research prototype at the lateral ribcage. Most of this heat flux will be the thermal energy transmitted from the participants body and is measured in watts per square meters.

    Participants will be monitored continuously and unobtrusively with the research prototypes over a 1-3 day time period, depending on the stationary stay in the hospital

  • Continuous and non-invasive skin temperature at the foot position

    Skin temperature data collected continuously and non-invasively using a research prototype at the foot. The skin temperature is measured directly underneath the research prototype on the surface of the skin in degree Celsius.

    Participants will be monitored continuously and unobtrusively with the research prototypes over a 1-3 day time period, depending on the stationary stay in the hospital

  • Continuous and non-invasive heat flux at the lateral foot position

    Heat flux data collected continuously and non-invasively using a research prototype at the foot. Most of this heat flux will be the thermal energy transmitted from the participants body and is measured in watts per square meters.

    Participants will be monitored continuously and unobtrusively with the research prototypes over a 1-3 day time period, depending on the stationary stay in the hospital

  • Sporadic rectal temperature measurement

    Rectal temperature will be measured every 8 hours by medical staff using the clinically established method of the hospital. This is a standard clinical routine and the precise timing of this measurement is determined by the medical staff according to their daily work routine.

    Every 8 hours over a 1-3 day time period, depending on the stationary stay in the hospital

  • Sporadic ear temperature measurements

    For infants older than 6 months of age only: Ear temperature will be measured every 4 hours using an infrared ear thermometer. The every second ear temperature measurement will coincide with the rectal temperature measurement.

    Every 4 hours over a 1-3 day time period, depending on the stationary stay in the hospital

Secondary Outcomes (2)

  • Heart rate

    Participants will be monitored continuously and unobtrusively with the research prototypes over a 1-3 day time period, depending on the stationary stay in the hospital

  • SpO2

    Participants will be monitored continuously and unobtrusively with the research prototypes over a 1-3 day time period, depending on the stationary stay in the hospital

Study Arms (1)

Unobtrusive data collection

OTHER
Other: Unobtrusive data collection using wearable non-invasive sensors

Interventions

Two wearable non-invasive sensors will be mounted to the patients skin (lateral rib cage and foot). These wearable non-invasive sensors are measuring unobtrusively skin based parameters (no diagnosis will be made), which will be used for fever detection algorithm development..

Unobtrusive data collection

Eligibility Criteria

Age2 Weeks - 18 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants from two weeks after birth and due date up to 18 months of age
  • Infants which are staying at the Nursery and the University Children's Hospital Zurich or Children's Hospital of Eastern Switzerland, St. Gallen for more than 1 day
  • Informed consent signed by parents or by legal representatives

You may not qualify if:

  • Acute medical contradiction against medical plaster and adhesives (e.g. skin diseases or allergies).
  • Irritated or damaged skin (e.g. burn, rush, eczema)
  • Infant with congenital anomalies (e.g. malformations of the anus)
  • Disease or brain injury which cause a disturbance of the thermoregulation
  • Comatose infant's
  • Infants with implants (e.g. pacemaker, cochlear implants)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Children's Hospital of Eastern Switzerland, St. Gallen

Sankt Gallen, 9000, Switzerland

Location

University Children's Hospital Zurich

Zurich, 8000, Switzerland

Location

MeSH Terms

Conditions

Fever

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Christoph Berger, Prof. Dr.

    University Children's Hospital, Zurich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2020

First Posted

December 4, 2020

Study Start

April 7, 2020

Primary Completion

March 30, 2025

Study Completion

March 30, 2025

Last Updated

March 15, 2024

Record last verified: 2024-03

Locations